Diversify Wealth Management LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Diversify Wealth Management LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 101.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,063 shares of the medical equipment provider's stock after acquiring an additional 4,066 shares during the period. Diversify Wealth Management LLC's holdings in Intuitive Surgical were worth $4,414,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of ISRG. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter worth about $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $38,000. Finally, DT Investment Partners LLC grew its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock worth $40,000 after acquiring an additional 36 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $8.56 during mid-day trading on Monday, hitting $592.64. 2,630,118 shares of the company traded hands, compared to its average volume of 1,158,623. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The stock has a 50-day moving average price of $540.66 and a two-hundred day moving average price of $499.64. The stock has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company's stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on ISRG. Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Leerink Partners lifted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.